Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort

Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as they may present with respiratory muscle weakness and because they are on immunosuppressive treatment; thereby, COVID-19 may have a detrimental effect on these patients. Vaccines against COVID-19 are currently ava...

Full description

Bibliographic Details
Main Authors: Antonino Lupica, Vincenzo Di Stefano, Salvatore Iacono, Antonia Pignolo, Martina Quartana, Andrea Gagliardo, Brigida Fierro, Filippo Brighina
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Neurology International
Subjects:
COVID-19
SARS-CoV2
vaccine
Myasthenia gravis
neuromuscular
myasthenic crisis
Online Access:https://www.mdpi.com/2035-8377/14/2/33

Internet

https://www.mdpi.com/2035-8377/14/2/33

Similar Items